Analgesic adjuvants modulate morphine-induced immune effects in mice

Area of Science:

• Immunology
• Pharmacology
• Pain Research

Background:

• Macrophages play a role in pain pathogenesis and respond to medications like adjuvant analgesics (AAs).
• AAs, including anticonvulsants and antidepressants, are effective for neuropathic pain.
• The immunomodulatory mechanisms of AAs' analgesic effects are not well-defined.

Purpose of the Study:

• To investigate the impact of AAs on morphine-induced effects on mouse immunity.
• To explore how AAs modulate macrophage functions in the context of morphine treatment.

Main Methods:

• Mice were treated with morphine and/or AAs (gabapentin, amitriptyline, venlafaxine).
• Macrophage functions including phagocytosis, cytokine generation, and antigen presentation were assessed.
• Humoral and cellular immune responses, as well as contact hypersensitivity, were evaluated.

Main Results:

• Morphine and AAs reduced antigen phagocytosis by macrophages.
• AAs modulated cytokine secretion, decreasing LPS-stimulated pro-inflammatory cytokines.
• Morphine and AAs impaired macrophage antigen presentation, reducing B-cell antibody production, with AAs potentiating this effect.
• Gabapentin and venlafaxine suppressed contact hypersensitivity; amitriptyline had a contrasting effect.

Conclusions:

• Adjuvant analgesics exhibit significant anti-inflammatory activity across various macrophage immune functions.
• This immunomodulatory activity is likely crucial for their analgesic effects and supports morphine's efficacy.